Schedule A Consultation
To smooth away moderate to severe lines and wrinkles, JUVÉDERM® XC:
- Provides instant results
- Is a nonsurgical treatment
- Provides natural-looking results
- Lasts up to 1 year with optimal treatment
- Contains modified hyaluronic acid (HA)
What is JUVÉDERM® XC?
JUVÉDERM® XC is a dermal filler designed to fill moderate to severe facial wrinkles and folds, like your “smile lines” or “parentheses,” to create a smooth look. Smile lines, or parentheses, are the creases that run from the bottom of your nose to the corners of your mouth.
JUVÉDERM® XC offers smooth and natural-looking results that last up to 1 year with optimal correction at initial treatment
Before the injection procedure, you will have a consultation with Dr. Shanthala. She will discuss whether JUVÉDERM® XC is appropriate for you, review your expectations and your desired results, as well as identify the areas to treat. She will also review any potential side effects.
JUVÉDERM® XC is nonsurgical, and you will begin to see results instantly. You should be able to get back to your full routine after 24 hours
JUVÉDERM® XC contains lidocaine, a numbing agent designed to minimize pain that can occur during treatment. Dr. Shanthala may also choose to numb the treatment area with a topical numbing cream to further minimize pain.
Results are instant. JUVÉDERM® XC lasts up to 1 year with optimal correction at initial treatment.
Dr. Shanthala will discuss any potential side effects during the consultation. With JUVÉDERM® XC, the most common side effects are redness, swelling, tenderness, firmness, itching, lumps/bumps, discoloration, and bruising at the injection site.
Brilliant Distinctions® allows you to earn points for savings on Allergan treatments such as BOTOX®, Juvéderm®, and Latisse®
If you’re looking for fillers such as JUVEDERM® XC performed by a physician in and around Peabody and Boston, request a consultation online, or contact us at (978) 854-5035 to schedule your appointment.
JUVÉDERM VOLUMA® XC injectable gel is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21.
IMPORTANT SAFETY INFORMATION
JUVÉDERM VOLUMA® XC is contraindicated for patients with severe allergies, manifested by a history of anaphylaxis or history or presence of multiple severe allergies, and a history of allergies to gram-positive bacterial proteins or lidocaine.
JUVÉDERM VOLUMA® XC injectable gel must not be injected into blood vessels and should not be used in vascular-rich areas. Use in these areas, such as glabella and nose, has resulted in cases of vascular embolization, occlusion of the vessels, ischemia or infarction, or blindness. Symptoms of vessel occlusion and embolization include pain that is disproportionate to the procedure or remote to the injection site, immediate blanching extending beyond the injected area, and color changes that reflect ischemic tissue such as a dusky or reticular appearance
Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled
The safety and effectiveness for the treatment of anatomic regions other than the mid-face have not been established
As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Follow standard precautions associated with injectable materials
The safety for use during pregnancy, in breastfeeding females, and in patients with very thin skin in the mid-face region has not been established
The safety for use in patients under 35 years or over 65 years has not been established
The safety in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied JUVÉDERM VOLUMA® XC injectable gel should be used with caution in patients on immunosuppressive therapy
Patients who are using products that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites
Patients who experience skin injury near the site of JUVÉDERM VOLUMA® XC implantation may be at a higher risk for adverse events
Patients may experience late onset nodules with use of dermal fillers including JUVÉDERM VOLUMA® XC
Patients should be limited to 20 mL of JUVÉDERM VOLUMA® XC per 60 kg (130 lbs) body mass per year. The safety of injecting greater amounts has not been established
JUVÉDERM VOLUMA® XC should only be used by physicians who have appropriate experience and who are knowledgeable about facial anatomy and theproduct for use in deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation
Side effects in > 5% of subjects were temporary injection-site tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. They were predominantly moderate in severity, with a duration of 2 to 4 weeks.
To report an adverse reaction, please call Allergan Product Surveillance at 1-877-345-5372.
For more information, please see the About Safety page at www.juvederm.com or call the Allergan Medical Information line at 1-800-433-8871.
JUVÉDERM VOLUMA® XC injectable gel is available by prescription only.